A theranostic approach based on radiolabeled antiviral drugs, antibodies and CRISPR-associated proteins for early detection and treatment of SARS-CoV-2 disease. Issue 9 (September 2020)

Record Type:: Journal Article
Title:: A theranostic approach based on radiolabeled antiviral drugs, antibodies and CRISPR-associated proteins for early detection and treatment of SARS-CoV-2 disease. Issue 9 (September 2020)
Main Title:: A theranostic approach based on radiolabeled antiviral drugs, antibodies and CRISPR-associated proteins for early detection and treatment of SARS-CoV-2 disease
Authors:: Shiri, Isaac
Abdollahi, Hamid
Atashzar, Mohammad Reza
Rahmim, Arman
Zaidi, Habib
Abstract:
Is Part Of:: Nuclear medicine communications. Volume 41:Issue 9(2020)
Journal:: Nuclear medicine communications
Issue:: Volume 41:Issue 9(2020)
Issue Display:: Volume 41, Issue 9 (2020)
Year:: 2020
Volume:: 41
Issue:: 9
Issue Sort Value:: 2020-0041-0009-0000
Page Start:
Page End:
Publication Date:: 2020-09
Subjects:: Nuclear medicine -- Periodicals
616.07575
Journal URLs:: http://journals.lww.com/nuclearmedicinecomm/pages/default.aspx ↗
http://journals.lww.com/pages/default.aspx ↗
http://www.lww.com/Product/0143-3636 ↗
DOI:: 10.1097/MNM.0000000000001269 ↗
Languages:: English
ISSNs:: 0143-3636
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 6180.923000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 14547.xml